Product Code: 745
Title:
Enteral Feeding Devices Market Size By Product (Giving Set, Enteral Feeding Pump, Percutaneous Endoscopic Gastrostomy Device, Low Profile Gastrostomy Device, Nasogastric Tube, Gastrostomy Tube), By End-use (Hospitals, Homecare) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, France, UK, Spain, Italy, India, China, Japan, Brazil, Mexico, Saudi Arabia, South Africa), Application Potential, Competitive Market Share & Forecast, 2018 - 2024.
Enteral Feeding Devices Market will exceed USD 3.5 billion by 2024; as per a new research report.
Growing geriatric population will drive enteral feeding devices market growth. Elderly population is more susceptible to infections such as cancer and diabetes that will increase the demand for enteral feeding devices. According to Census Bureau, in 2014, 14.2% of the total population belonged to the age group of 65 years and above and majority of them suffered from at least one chronic disease that will have a positive impact on enteral feeding devices industry.
Increasing prevalence of chronic diseases should augment enteral feeding devices market growth over the forecast timeframe. Around 60% Americans have at least one chronic disease that will elevate demand for enteral feeding devices. Moreover, technological advancements will improve the quality of devices thereby, boosting business growth in the near future. However, complications linked with enteral feeding devices may hamper as the patient's life is at a risk.
Gastrostomy tube segment was valued at USD 183.3 million in 2017. Increasing gastrointestinal diseases and growing usage of gastrotomy feeding tube for children, to administer medicine and liquids will thereby, fuel business growth. Furthermore, rising demand for minimal invasive laparoscopically assisted gastrostomy will positively impact the segmental growth.
Homecare segment of enteral feeding devices market will grow at 6.6% over the forecast timeframe and the high growth can be accounted to the increasing preference for enteral feeding devices utilized at home. Home enteral therapy is convenient proving to be time and cost-efficient option thereby, will influence the segmental growth positively.
U.S. enteral feeding devices market valued at USD 659.5 million in 2017. According to the National Centre for Health statistics, patients received tube feeding in over 240,000 hospital stays, approximately 15% of those were for new-borns and children that should stimulate the business growth. Increasing aging population, growing incidence and prevalence of diseases such as cancer, cardiovascular, diabetes, dementia and increased premature births in U.S will fuel enteral feeding devices market in coming years.
China enteral feeding devices market held an enormous revenue share of 29.8% in 2017 and considerable revenue share can be attributed to the growing cases of diabetes. According to China FDA, China accounts to 48% of the total world population that suffers from diabetes. Also, the prevalence of metabolic syndrome (MetS) is high and increasing rapidly among Chinese elderly population increasing the number of surgical procedures thereby, should augment enteral feeding devices industry growth.
Some of the prominent industry players are ALCOR Scientific, Abbott Nutrition, Amsino International, Applied Medical Technologies, Baxter International, B. Braun Melsungen, Becton Dickinson, Boston Scientific, Cardinal Health, Cook Medical, ConMed, Danone, Degania Silicone, Fresenius Kabi, Halyard Health, Moog, Nestle, and Vygon.
Strategic initiatives adopted by these prominent leaders will upsurge their profits and respective market shares. For instance, in February 2017, Baxter announced the launch of Enteral Nutrition ENFit Syringe and Accesory Line. The launch was envisioned with an aim to ensure patients to have safe access to nutrition therapy thereby, strengthening Baxter's product portfolio.
Table of Contents
Chapter 1. Methodology
- 1.1. Methodology
- 1.2. Market definitions
- 1.3. Forecast parameters
- 1.4. Data sources
- 1.4.1. Secondary
- 1.4.1.1. Paid sources
- 1.4.1.2. Unpaid sources
- 1.4.2. Primary
Chapter 2. Executive Summary
- 2.1. Enteral feeding devices industry 360 degree synopsis, 2013 - 2024
- 2.1.1. Business trends
- 2.1.2. Product type trends
- 2.1.3. End-use trends
- 2.1.4. Regional trends
Chapter 3. Enteral Feeding Devices Industry Insights
- 3.1. Industry segmentation
- 3.2. Industry landscape, 2013 - 2024
- 3.3. Industry impact forces
- 3.3.1. Growth drivers
- 3.3.1.1. Growing geriatric population base in Europe
- 3.3.1.2. Growing prevalence of chronic diseases in Europe and Africa
- 3.3.1.3. Technological advancements in enteral feeding devices in North America
- 3.3.1.4. Growing demand for neonatal and preterm enteral feeding in UK and Asia Pacific
- 3.3.2. Industry pitfalls and challenges
- 3.3.2.1. Complications associated with the small-bore connectors
- 3.3.2.2. Risks associated with enteral feeding
- 3.4. Growth potential analysis
- 3.4.1. By product
- 3.4.2. By end-use
- 3.5. Regulatory landscape
- 3.6. Reimbursement scenario
- 3.7. Technology landscape
- 3.8. Competitive landscape, 2017
- 3.8.1. Company market share analysis
- 3.9. Strategy dashboard
- 3.10. Porter's analysis
- 3.11. PESTEL analysis
Chapter 4. Enteral Feeding Devices Market, By Product
- 4.1. Key segment trends
- 4.2. Giving set
- 4.2.1. Market size, by region, 2013-2024 (USD Million)
- 4.3. Enteral feeding pump
- 4.3.1. Market size, by region, 2013-2024 (USD Million)
- 4.4. Percutaneous endoscopic gastronomy devices
- 4.4.1. Market size, by region, 2013-2024 (USD Million)
- 4.5. Low profile gastronomy devices
- 4.5.1. Market size, by region, 2013-2024 (USD Million)
- 4.6. Nasogastric tube
- 4.6.1. Market size, by region, 2013-2024 (USD Million)
- 4.7. Gastrostomy tube
- 4.7.1. Market size, by region, 2013-2024 (USD Million)
Chapter 5. Enteral Feeding Devices Market, By End-use
- 5.1. Key segment trend
- 5.2. Hospitals
- 5.2.1. Market size, by region, 2013-2024 (USD Million)
- 5.3. Homecare
- 5.3.1. Market size, by region, 2013-2024 (USD Million)
- 5.4. Others
- 5.4.1. Market size, by region, 2013-2024 (USD Million)
Chapter 6. Enteral Feeding Devices Market, By Region
- 6.1. Key regional market
- 6.2. North America
- 6.2.1. Market size, by country, 2013 - 2024(USD Million)
- 6.2.2. Market size, by product, 2013 - 2024(USD Million)
- 6.2.3. Market size, by end-use, 2013 - 2024(USD Million)
- 6.2.4. U.S.
- 6.2.4.1. Market size, by product, 2013 - 2024(USD Million)
- 6.2.4.2. Market size, by end-use, 2013 - 2024(USD Million)
- 6.2.5. Canada
- 6.2.5.1. Market size, by product, 2013 - 2024(USD Million)
- 6.2.5.2. Market size, by end-use, 2013 - 2024(USD Million)
- 6.3. Europe
- 6.3.1. Market size, by country, 2013 - 2024(USD Million)
- 6.3.2. Market size, by product, 2013 - 2024(USD Million)
- 6.3.3. Market size, by end-use, 2013 - 2024(USD Million)
- 6.3.4. Germany
- 6.3.4.1. Market size, by product, 2013 - 2024(USD Million)
- 6.3.4.2. Market size, by end-use, 2013 - 2024(USD Million)
- 6.3.5. UK
- 6.3.5.1. Market size, by product, 2013 - 2024(USD Million)
- 6.3.5.2. Market size, by end-use, 2013 - 2024(USD Million)
- 6.3.6. France
- 6.3.6.1. Market size, by product, 2013 - 2024(USD Million)
- 6.3.6.2. Market size, by end-use, 2013 - 2024(USD Million)
- 6.3.7. Spain
- 6.3.7.1. Market size, by product, 2013 - 2024(USD Million)
- 6.3.7.2. Market size, by end-use, 2013 - 2024(USD Million)
- 6.3.8. Italy
- 6.3.8.1. Market size, by product, 2013 - 2024(USD Million)
- 6.3.8.2. Market size, by end-use, 2013 - 2024(USD Million)
- 6.4. Asia Pacific
- 6.4.1. Market size, by country, 2013 - 2024(USD Million)
- 6.4.2. Market size, by product, 2013 - 2024(USD Million)
- 6.4.3. Market size, by end-use, 2013 - 2024(USD Million)
- 6.4.4. India
- 6.4.4.1. Market size, by product, 2013 - 2024(USD Million)
- 6.4.4.2. Market size, by end-use, 2013 - 2024(USD Million)
- 6.4.5. China
- 6.4.5.1. Market size, by product, 2013 - 2024(USD Million)
- 6.4.5.2. Market size, by end-use, 2013 - 2024(USD Million)
- 6.4.6. Japan
- 6.4.6.1. Market size, by product, 2013 - 2024(USD Million)
- 6.4.6.2. Market size, by end-use, 2013 - 2024(USD Million)
- 6.5. Latin America
- 6.5.1. Market size, by country, 2013 - 2024(USD Million)
- 6.5.2. Market size, by product, 2013 - 2024(USD Million)
- 6.5.3. Market size, by end-use, 2013 - 2024(USD Million)
- 6.5.4. Brazil
- 6.5.4.1. Market size, by product, 2013 - 2024(USD Million)
- 6.5.4.2. Market size, by end-use, 2013 - 2024(USD Million)
- 6.5.5. Mexico
- 6.5.5.1. Market size, by product, 2013 - 2024(USD Million)
- 6.5.5.2. Market size, by end-use, 2013 - 2024(USD Million)
- 6.6. MEA
- 6.6.1. Market size, by country, 2013 - 2024(USD Million)
- 6.6.2. Market size, by product, 2013 - 2024(USD Million)
- 6.6.3. Market size, by end-use, 2013 - 2024(USD Million)
- 6.6.4. South Africa
- 6.6.4.1. Market size, by product, 2013 - 2024(USD Million)
- 6.6.4.2. Market size, by end-use, 2013 - 2024(USD Million)
- 6.6.5. Saudi Arabia
- 6.6.5.1. Market size, by product, 2013 - 2024(USD Million)
- 6.6.5.2. Market size, by end-use, 2013 - 2024(USD Million)
Chapter 7. Company Profiles
- 7.1. ALCOR
- 7.1.1. Business overview
- 7.1.2. Financial data
- 7.1.3. Product landscape
- 7.1.4. Strategic outlook
- 7.1.5. SWOT analysis
- 7.2. Abbott Nutrition
- 7.2.1. Business overview
- 7.2.2. Financial data
- 7.2.3. Product landscape
- 7.2.4. Strategic outlook
- 7.2.5. SWOT analysis
- 7.3. Amsino International
- 7.3.1. Business overview
- 7.3.2. Financial data
- 7.3.3. Product landscape
- 7.3.4. Strategic outlook
- 7.3.5. SWOT analysis
- 7.4. Applied Medical Technologies
- 7.4.1. Business overview
- 7.4.2. Financial data
- 7.4.3. Product landscape
- 7.4.4. Strategic outlook
- 7.4.5. SWOT analysis
- 7.5. Baxter International
- 7.5.1. Business overview
- 7.5.2. Financial data
- 7.5.3. Product landscape
- 7.5.4. Strategic outlook
- 7.5.5. SWOT analysis
- 7.6. B. Braun Melsungen
- 7.6.1. Business overview
- 7.6.2. Financial data
- 7.6.3. Product landscape
- 7.6.4. Strategic outlook
- 7.6.5. SWOT analysis
- 7.7. Becton Dickinson (C.R. Bard, Inc.)
- 7.7.1. Business overview
- 7.7.2. Financial data
- 7.7.3. Product landscape
- 7.7.4. Strategic outlook
- 7.7.5. SWOT analysis
- 7.8. Boston Scientific Corporation
- 7.8.1. Business overview
- 7.8.2. Financial data
- 7.8.3. Product landscape
- 7.8.4. Strategic outlook
- 7.8.5. SWOT analysis
- 7.9. Cardinal Health, Inc.
- 7.9.1. Business overview
- 7.9.2. Financial data
- 7.9.3. Product landscape
- 7.9.4. Strategic outlook
- 7.9.5. SWOT analysis
- 7.10. Cook Medical
- 7.10.1. Business overview
- 7.10.2. Financial data
- 7.10.3. Product landscape
- 7.10.4. Strategic outlook
- 7.10.5. SWOT analysis
- 7.11. ConMed Corporation
- 7.11.1. Business overview
- 7.11.2. Financial data
- 7.11.3. Product landscape
- 7.11.4. Strategic outlook
- 7.11.5. SWOT analysis
- 7.12. Danone
- 7.12.1. Business overview
- 7.12.2. Financial data
- 7.12.3. Product landscape
- 7.12.4. Strategic outlook
- 7.12.5. SWOT analysis
- 7.13. Degania Silicone Ltd.
- 7.13.1. Business overview
- 7.13.2. Financial data
- 7.13.3. Product landscape
- 7.13.4. Strategic outlook
- 7.13.5. SWOT analysis
- 7.14. Fresenius Kabi AG
- 7.14.1. Business overview
- 7.14.2. Financial data
- 7.14.3. Product landscape
- 7.14.4. Strategic outlook
- 7.14.5. SWOT analysis
- 7.15. Halyard Health, Inc.
- 7.15.1. Business overview
- 7.15.2. Financial data
- 7.15.3. Product landscape
- 7.15.4. Strategic outlook
- 7.15.5. SWOT analysis
- 7.16. Halyard Health
- 7.16.1. Business overview
- 7.16.2. Financial data
- 7.16.3. Product landscape
- 7.16.4. Strategic outlook
- 7.16.5. SWOT analysis
- 7.17. Moog Inc.
- 7.17.1. Business overview
- 7.17.2. Financial data
- 7.17.3. Product landscape
- 7.17.4. Strategic outlook
- 7.17.5. SWOT analysis
- 7.18. Nestle Inc.
- 7.18.1. Business overview
- 7.18.2. Financial data
- 7.18.3. Product landscape
- 7.18.4. Strategic outlook
- 7.18.5. SWOT analysis
- 7.19. Vygon
- 7.19.1. Business overview
- 7.19.2. Financial data
- 7.19.3. Product landscape
- 7.19.4. Strategic outlook
- 7.19.5. SWOT analysis
比較リスト
